ArticleHuman vaccines & immunotherapeutics2023

Immune checkpoint inhibitors as first-line therapy for non-small cell lung cancer: A systematic evaluation and meta-analysis.

Yu Lu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.